<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20080910/bs_nm/imclone_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20080910/2008_09_10t093247_450x346_us_imclone.jpg?x=130&y=9 9&q=85&sig=YM2SR36ZmhLwnM9njW4GYg--" align="left" height="99" width="130" alt="Carl Icahn, the billionaire investor and chairman of ImClone's board, in a file photo. (Chip East/Reuters)" border="0" /></a>Reuters - ImClone Systems Inc said on
Wednesday it has received a takeover offer of $70 a share from
a large pharmaceutical company, topping an earlier bid of $60 a
share from Bristol-Myers Squibb Co and sending its
shares up 7 percent.</p><br clear="all"/>

View the entire article: ImClone says it received $70-a-share buyout offer
(Reuters)